Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Employees
Common Stock
Executive Officer
Common Stock
Director
Common Stock
Beginning balance (in shares) at Mar. 31, 2022   33,364,722            
Beginning balance at Mar. 31, 2022 $ 399,204 $ 33 $ 234,549 $ 203,528 $ (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           30,352 64,294 8,766
Stock compensation expense 1,193   1,193          
Repurchase of employee stock units on vesting (552)   (552)          
Net income (loss) 6,556     6,556        
Foreign currency translation adjustment (5,152)       (5,152)      
Other 3     1 2      
Ending balance (in shares) at Jun. 30, 2022   33,468,134            
Ending balance at Jun. 30, 2022 401,252 $ 33 235,190 210,085 (44,056)      
Beginning balance (in shares) at Mar. 31, 2022   33,364,722            
Beginning balance at Mar. 31, 2022 399,204 $ 33 234,549 203,528 (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 17,540              
Ending balance (in shares) at Sep. 30, 2022   33,483,608            
Ending balance at Sep. 30, 2022 395,758 $ 33 236,407 221,069 (61,751)      
Beginning balance (in shares) at Jun. 30, 2022   33,468,134            
Beginning balance at Jun. 30, 2022 401,252 $ 33 235,190 210,085 (44,056)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           5,544   9,930
Stock compensation expense 1,251   1,251          
Repurchase of employee stock units on vesting (34)   (34)          
Net income (loss) 10,984     10,984        
Foreign currency translation adjustment (17,811)       (17,811)      
Other 116       116      
Ending balance (in shares) at Sep. 30, 2022   33,483,608            
Ending balance at Sep. 30, 2022 $ 395,758 $ 33 236,407 221,069 (61,751)      
Beginning balance (in shares) at Mar. 31, 2023 33,508,076 33,508,076            
Beginning balance at Mar. 31, 2023 $ 418,988 $ 33 239,860 237,195 (58,100)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           73,345 93,826 5,718
Stock compensation expense 1,238   1,238          
Repurchase of employee stock units on vesting (1,685)   (1,685)          
Net income (loss) 10,938     10,938        
Foreign currency translation adjustment 4,457       4,457      
Other 13       13      
Ending balance (in shares) at Jun. 30, 2023   33,680,965            
Ending balance at Jun. 30, 2023 $ 433,949 $ 33 239,413 248,133 (53,630)      
Beginning balance (in shares) at Mar. 31, 2023 33,508,076 33,508,076            
Beginning balance at Mar. 31, 2023 $ 418,988 $ 33 239,860 237,195 (58,100)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 25,668              
Ending balance (in shares) at Sep. 30, 2023 33,690,712 33,690,712            
Ending balance at Sep. 30, 2023 $ 442,306 $ 34 240,833 262,863 (61,424)      
Beginning balance (in shares) at Jun. 30, 2023   33,680,965            
Beginning balance at Jun. 30, 2023 433,949 $ 33 239,413 248,133 (53,630)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           2,550   7,197
Stock compensation expense 1,450   1,450          
Repurchase of employee stock units on vesting (30)   (30)          
Net income (loss) 14,730     14,730        
Foreign currency translation adjustment (7,845)       (7,845)      
Other $ 52 $ 1     51      
Ending balance (in shares) at Sep. 30, 2023 33,690,712 33,690,712            
Ending balance at Sep. 30, 2023 $ 442,306 $ 34 $ 240,833 $ 262,863 $ (61,424)